Tambay, V.; Raymond, V.-A.; Turcotte, S.; Bilodeau, M.
Glutaminase Reprogramming in Hepatocellular Carcinoma: Implications for Diagnosis, Prognosis, and Potential as a Novel Therapeutic Target. Int. J. Mol. Sci. 2025, 26, 9653.
https://doi.org/10.3390/ijms26199653
AMA Style
Tambay V, Raymond V-A, Turcotte S, Bilodeau M.
Glutaminase Reprogramming in Hepatocellular Carcinoma: Implications for Diagnosis, Prognosis, and Potential as a Novel Therapeutic Target. International Journal of Molecular Sciences. 2025; 26(19):9653.
https://doi.org/10.3390/ijms26199653
Chicago/Turabian Style
Tambay, Vincent, Valérie-Ann Raymond, Simon Turcotte, and Marc Bilodeau.
2025. "Glutaminase Reprogramming in Hepatocellular Carcinoma: Implications for Diagnosis, Prognosis, and Potential as a Novel Therapeutic Target" International Journal of Molecular Sciences 26, no. 19: 9653.
https://doi.org/10.3390/ijms26199653
APA Style
Tambay, V., Raymond, V.-A., Turcotte, S., & Bilodeau, M.
(2025). Glutaminase Reprogramming in Hepatocellular Carcinoma: Implications for Diagnosis, Prognosis, and Potential as a Novel Therapeutic Target. International Journal of Molecular Sciences, 26(19), 9653.
https://doi.org/10.3390/ijms26199653